Lipoprotein-associated phospholipase A2 predicts cardiovascular events in dialyzed patients

被引：0
|
作者：
Andreana De Mauri
Matteo Vidali
Doriana Chiarinotti
Giorgio Bellomo
Roberta Rolla
机构：
[1] “Maggiore della Carità” University Hospital,Nephrology and Dialysis Unit
[2] Amedeo Avogadro University of Eastern Piedmont,Department of Health Sciences
[3] “Maggiore della Carità” University Hospital,Clinical Chemistry Laboratory
来源：
Journal of Nephrology | 2019年 / 32卷
关键词：
Lipoprotein-associated phospholipase A2; Cardiovascular disease; Hemodialysis; Mortality; Atherosclerosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：283 / 288
页数：5
相关论文
共 50 条
  • [21] Lipoprotein-associated phospholipase A2 single-nucleotide polymorphisms and cardiovascular events in patients with coronary artery disease
    Maiolino, Giuseppe
    Lenzini, Livia
    Pedon, Luigi
    Cesari, Maurizio
    Seccia, Teresa Maria
    Frigo, Anna Chiara
    Rossitto, Giacomo
    Caroccia, Brasilina
    Rossi, Gian Paolo
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2015, 16 (01) : 29 - 36
  • [22] Role of lipoprotein-associated phospholipase A2 in predicting risk of cardiovascular disease
    Myerson, Merle
    MAYO CLINIC PROCEEDINGS, 2007, 82 (07) : 888 - 888
  • [23] Is lipoprotein-associated phospholipase A2 correlated with cardiovascular risk in European women?
    Hirschler, V.
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2013, 138 : 832 - 833
  • [24] Lipoprotein-Associated and Secretory Phospholipase A2 in Cardiovascular Disease: The Epidemiological Evidence
    Koenig, Wolfgang
    Khuseyinova, Natalie
    CARDIOVASCULAR DRUGS AND THERAPY, 2009, 23 (01) : 85 - 92
  • [25] Association of lipoprotein-associated phospholipase activity A2 with cardiovascular risk factors
    Acevedo, Monica
    Varleta, Paola
    Kramer, Veronica
    Quiroga, Teresa
    Prieto, Carolina
    Parada, Jacqueline
    Adasme, Marcela
    Briones, Luisa
    Navarrete, Carlos
    REVISTA MEDICA DE CHILE, 2013, 141 (11) : 1382 - 1388
  • [26] Lipoprotein-associated phospholipase A2 and cardiovascular disease risk in HIV infection
    Eckard, A. Ross
    Longenecker, C. T.
    Jiang, Y.
    Debanne, S. M.
    Labbato, D.
    Storer, N.
    McComsey, G. A.
    HIV MEDICINE, 2014, 15 (09) : 537 - 546
  • [27] Lipoprotein-associated phospholipase A2 is associated with cardiovascular disease:: Results of a systematic review
    Garza, AC
    McConnell, J
    Montori, VM
    Somers, V
    Lopez-Jimenez, F
    CIRCULATION, 2006, 113 (08) : E366 - E366
  • [28] Lipoprotein-associated phospholipase A2 and risk of dementia in the Cardiovascular Health Study
    Fitzpatrick, Annette L.
    Irizarry, Michael C.
    Cushman, Mary
    Jenny, Nancy S.
    Chi, Gloria C.
    Koro, Carol
    ATHEROSCLEROSIS, 2014, 235 (02) : 384 - 391
  • [29] Lipoprotein-Associated and Secretory Phospholipase A2 in Cardiovascular Disease: The Epidemiological Evidence
    Wolfgang Koenig
    Natalie Khuseyinova
    Cardiovascular Drugs and Therapy, 2009, 23
  • [30] New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease
    Tsimikas, Sotirios
    Tsironis, Loukas D.
    Tselepis, Alexandros D.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (10) : 2094 - 2099
12345